Evidence map›Paper›PMID 40598894›Full record

ArticleNucleic acids research2025

A-to-I mRNA editing in bacteria can affect protein sequence, disulfide bond formation, and function.

Liron Didi, Ofir Fargeon, Liam Aspit, Eyal Elias, Dor Braverman, Dganit Melamed, Daniel Keidar-Friedman, Nadav Sorek, Orit Raz, Sharon Ovnat Tamir and 5 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Compendium of RNA modifications for bacterial stress adaptation.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Evolution of Engineered ADAR-Based RNA Editing Systems.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Liron DidiThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.
Ofir FargeonThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.
Liam AspitThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.
Eyal EliasThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.
Dor BravermanThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.
Dganit MelamedThe Smoler Protein Research Center, Technion Israel Institute of Technology, Haifa, 3200003 Israel.
Daniel Keidar-FriedmanAssuta Ashdod University Hospital, Faculty of Health Sciences, Ben-Gurion University of the Negev, Ashdod, 7747629 Israel.
Nadav SorekAssuta Ashdod University Hospital, Faculty of Health Sciences, Ben-Gurion University of the Negev, Ashdod, 7747629 Israel.
Orit RazAssuta Ashdod University Hospital, Faculty of Health Sciences, Ben-Gurion University of the Negev, Ashdod, 7747629 Israel.
Sharon Ovnat TamirAssuta Ashdod University Hospital, Faculty of Health Sciences, Ben-Gurion University of the Negev, Ashdod, 7747629 Israel.
Raz ZarivachDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.
Neta Sal-ManThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.ORCID 0000-0002-1109-479X
Orna DahanDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, 7610001 Israel.
Yitzhak PilpelDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, 7610001 Israel.
Dan Bar YaacovThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, 8410501 Israel.ORCID 0000-0002-0599-5153

Funding

Assuta Ashdod University HospitalEuropean Research Council 101116636-REDBACFaculty of Health SciencesIsrael Science Foundation 376/2023Minerva Center for Live Emulation of Evolution
6 · The paper itself

Abstract

Adenosine-to-inosine (A-to-I) mRNA editing can alter genetic information at the RNA level and is known to affect protein sequence and function in eukaryotes. However, the ability of A-to-I mRNA editing to recode protein sequences in bacteria was never shown at the protein level. Furthermore, the effect of A-to-I mRNA editing itself-not by A-to-G DNA-mimicking mutations-on protein function was never demonstrated in bacteria. Here, we show at the RNA and protein levels that A-to-I mRNA editing directly recodes a tyrosine to a cysteine residue in the toxin HokB (part of the HokB/sokB toxin-antitoxin system in Escherichia coli). Consequently, the toxicity of edited HokB increases, inducing bacterial death or early entrance into the stationary phase, depending on its expression level. Furthermore, we demonstrate that in vivo disulfide bond formation underlies the effect of A-to-I mRNA editing on HokB function, suggesting that A-to-I mRNA editing constitutes a novel mechanism to regulate disulfide bond formation in bacteria. Finally, we observe that A-to-I mRNA editing of hokB is conserved in pathogenic bacteria, supporting functional importance with possible clinical relevance. Our work reveals that A-to-I mRNA editing can constitute a novel mechanism to regulate protein sequence, disulfide bonds, and function in bacteria.

Indexed as

AdenosineBacterial ToxinsDisulfidesEscherichia coliEscherichia coli ProteinsInosineRNA EditingRNA, MessengerAmino Acid SequenceCysteineToxin-Antitoxin SystemsAdenosineBacterial ToxinsCysteineDisulfidesEscherichia coli ProteinsInosineRNA, Messenger

Identifiers

PMID40598894
PMCPMC12214031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.